Your Location:
Home >
Browse articles >
Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia

Scan QR Code

Alert me when the article has been cited
Submit
Research Article | Updated:2025-05-28
    • Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia

    • 药物抑制ENaC或NCX可减轻高钠血症加重的肝脏缺血再灌注损伤
    • Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)   Vol. 26, Issue 5, Pages: 461-476(2025)
    • DOI:10.1631/jzus.B2300825    

      CLC:
    • Received:14 November 2023,

      Revised:22 April 2024,

      Published:28 May 2025

  • Yabin CHEN, Hao LI, Peihao WEN, et al. Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia[J]. Journal of zhejiang university-science b (biomedicine & biotechnology), 2025, 26(5): 461-476. DOI: 10.1631/jzus.B2300825.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0